Product 457/3637

 Previous 
 Return to the Product List 
 Next 

Capitalizing a Cure: How Finance Controls the Price and Value of Medicines

  • ISBN 9780520388710
  • Author: Roy, Victor
  • Publ Date: 2023-01-24
  • Edition:
  • Binding: Paperback / softback

$60.87
Sale: $54.78
Save: 10% off + GST

Add to Cart:
A free open access ebook is available upon publication. Learn more at www.luminosoa.org.

Capitalizing a Cure takes readers into the struggle over accessing a medical breakthrough to investigate the power of finance over business, biomedicine, and public health. When sofosbuvir-based medicines launched in 2013, they promised a cure for millions of patients worldwide with hepatitis C. But their sticker shock-the drug was dubbed "the $1,000-a-day pill"-intensified a global debate over the pricing of new medicines. Weaving extensive historical research with insights from political economy and science and technology studies, Victor Roy demystifies an oft-missed dynamic in this debate: the reach of financialized capitalism into how medicines are made, priced, and valued.

Roy's account moves between public and private labs, Wall Street and corporate board rooms, public health meetings and health centers to trace the ways sofosbuvir-based medicines became financial assets dominated by strategies of speculation and extraction at the expense of access and care. Provocative and sobering, this book illuminates the harmful impact of allowing financial markets to supersede democracy and human health and points to the necessary work of building more equitable futures.
Whilst every effort is made to keep pricing information up-to-date, prices and availability are subject to change without notice. Where prices or other details have changed from those listed on the website we will contact the customer and only proceed with the order after receiving acceptance of the revised pricing.
Your IP Address is: 3.137.157.45
Copyright © 2024 Medical Books. Powered by Zen Cart